FR2822955B1 - Methode de diagnostic de maladies inflammatoires chroniques de l'intestin - Google Patents

Methode de diagnostic de maladies inflammatoires chroniques de l'intestin

Info

Publication number
FR2822955B1
FR2822955B1 FR0104128A FR0104128A FR2822955B1 FR 2822955 B1 FR2822955 B1 FR 2822955B1 FR 0104128 A FR0104128 A FR 0104128A FR 0104128 A FR0104128 A FR 0104128A FR 2822955 B1 FR2822955 B1 FR 2822955B1
Authority
FR
France
Prior art keywords
inflammatory bowel
chronic inflammatory
bowel diseases
diagnosing chronic
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0104128A
Other languages
English (en)
Other versions
FR2822955A1 (fr
Inventor
Pierre Desreumaux
Jean Frederic Colombel
Laurent Dubuquoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Hospitalier Universitaire de Lille CHU
Original Assignee
Centre Hospitalier Regional Universitaire de Lille CHRU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Regional Universitaire de Lille CHRU filed Critical Centre Hospitalier Regional Universitaire de Lille CHRU
Priority to FR0104128A priority Critical patent/FR2822955B1/fr
Priority to US10/473,480 priority patent/US20040132110A1/en
Priority to EP02753742A priority patent/EP1373906A1/fr
Priority to PCT/FR2002/001076 priority patent/WO2002077651A1/fr
Publication of FR2822955A1 publication Critical patent/FR2822955A1/fr
Application granted granted Critical
Publication of FR2822955B1 publication Critical patent/FR2822955B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0104128A 2001-03-27 2001-03-27 Methode de diagnostic de maladies inflammatoires chroniques de l'intestin Expired - Fee Related FR2822955B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0104128A FR2822955B1 (fr) 2001-03-27 2001-03-27 Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
US10/473,480 US20040132110A1 (en) 2001-03-27 2002-03-27 Method for diagnosing chronic intestinal inflammatory diseases
EP02753742A EP1373906A1 (fr) 2001-03-27 2002-03-27 Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
PCT/FR2002/001076 WO2002077651A1 (fr) 2001-03-27 2002-03-27 Methode de diagnostic de maladies inflammatoires chroniques de l'intestin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0104128A FR2822955B1 (fr) 2001-03-27 2001-03-27 Methode de diagnostic de maladies inflammatoires chroniques de l'intestin

Publications (2)

Publication Number Publication Date
FR2822955A1 FR2822955A1 (fr) 2002-10-04
FR2822955B1 true FR2822955B1 (fr) 2003-10-03

Family

ID=8861595

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0104128A Expired - Fee Related FR2822955B1 (fr) 2001-03-27 2001-03-27 Methode de diagnostic de maladies inflammatoires chroniques de l'intestin

Country Status (4)

Country Link
US (1) US20040132110A1 (fr)
EP (1) EP1373906A1 (fr)
FR (1) FR2822955B1 (fr)
WO (1) WO2002077651A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1844158A4 (fr) * 2004-12-06 2010-09-08 Univ Johns Hopkins Biomarqueurs pour maladie intestinale inflammatoire
ITRM20050390A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
ES2630044T3 (es) 2009-02-16 2017-08-17 Nogra Pharma Limited Compuestos de alquilamido y usos de los mismos
US8858924B2 (en) * 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
KR102067848B1 (ko) 2012-02-09 2020-01-17 노그라 파마 리미티드 섬유증의 치료 방법
CA2870490A1 (fr) 2012-04-18 2013-10-24 Nogra Pharma Limited Methodes de traitement de l'intolerance au lactose
EP3094973B1 (fr) 2013-11-07 2020-07-29 Diagnodus Limited Biomarqueurs
US11905232B2 (en) 2019-02-08 2024-02-20 Nogra Pharma Limited Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861274A (en) * 1990-03-22 1999-01-19 The Salk Institute For Biological Studies Nucleic acids encoding peroxisome proliferator-activated receptor
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method

Also Published As

Publication number Publication date
FR2822955A1 (fr) 2002-10-04
EP1373906A1 (fr) 2004-01-02
WO2002077651A1 (fr) 2002-10-03
US20040132110A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
DK1581119T3 (da) Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme
DK1712920T3 (da) Tidlig diagnose af konformationelle sygdomme
FR2733766B1 (fr) Methode de diagnostic de la schizophrenie
DE50209802D1 (de) Naht-set für medizinische zwecke
EP1543036A4 (fr) Proteine utilisee dans le diagnostic de la retinopathie diabetique
DE60321159D1 (de) Schiebeglas, abdeckglas und pathologisches diagnosesystem
DE60223874D1 (de) Ultraschalldiagnostikgerät
AU2003298703A1 (en) Diagnostic tests and methods for diagnosing inflammatory bowel disease
DE60206241D1 (de) Fehlerdiagnose
FR2822955B1 (fr) Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
AU2002221906A1 (en) Method for diagnosing allergic diseases
DE60234821D1 (de) Messverfahren für vollblut
EP1424931A4 (fr) Diagnostic precoce des accidents vasculaires cerebraux
AU2003212246A8 (en) Method for diagnosis of inflammatory diseases using mrp8/mrp14
GB0124315D0 (en) Inflammatory bowel disease
AU2002210438A1 (en) Diagnosis of diseases which are associated with cd24
NO20031941D0 (no) Diagnostisk fremgangsmåte
AU2003294206A8 (en) Methods for diagnosing htlv-i-mediated diseases
ITMI20001002A0 (it) Metodo e apparecchiatura per la diagnosi precoce di tumori vescicali su campioni di urina
FR2828212B1 (fr) Methodes de diagnostic et de pronostic de la maladie de parkinson
GB0224326D0 (en) Diagnostic tests
FR2845005B1 (fr) Kit d'evaluation ou de diagnostic
DE60328937D1 (de) Objektivdiagnostik
AU2002308038A1 (en) Method for diagnosing chronic intestinal inflammatory diseases
NO20015802D0 (no) Diagnostisk metode

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091130